Business Context and Reporting Period
This Form 8-K is a current report filed by Biocardia, Inc. (BCDA) on September 9, 2024, regarding events occurring on September 3, 2024. The company is incorporated in Delaware and trades on the Nasdaq Capital Market.
Key Financial Metrics
The filing reports the closing of a public offering. Specific financial metrics such as revenue, profit, cash flow, margins, and existing debt levels are not disclosed in this specific document.
- Capital Raised: $7.2 million from a public offering.
- Offering Date: September 3, 2024.
Material Changes
The primary material change reported is the successful completion of the $7.2 million public offering, which increases the company's cash liquidity. No comparative period financial data is provided in this filing to assess changes in operating performance.
Guidance, Outlook, and Risks
This filing does not contain forward-looking guidance, management commentary on future operations, or a discussion of specific risks and contingencies beyond the standard disclosure of the offering event. The filing references a press release (Exhibit 99.1) for further details on the offering.
Investor Verification Checklist
- Verify the final number of shares issued and the price per share in the attached press release (Exhibit 99.1).
- Confirm the use of proceeds from the $7.2 million offering.
- Review the company's most recent 10-Q or 10-K for baseline revenue, cash position, and debt levels not included in this 8-K.
- Check for any underwriting agreements or lock-up periods associated with the offering.